Press release – 2012
- November 1, 2012
Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program
- July 23, 2012
Alethia Biotherapeutics Obtains a Notice of Allowance for a Patent for the Use of Anti-Siglec-15 Antibodies
- May 1, 2012
Alethia Biotherapeutics Announces Issuance of a Patent for the Use of Anti-Resorptive Antibodies for Treatment of Severe Bone Loss
Alethia Press Release 120501 EN
- March 9, 2012
Alethia Biotherapeutics Announces the Filing of a US Provisional Patent Application Covering New Treatment Methods for its EMT Inhibitor AB-16B5